MarketInOut Stock Screener Log In | Sign Up
 

Revelation Biosciences Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/23/2026
Revelation Biosciences Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization2.16 mln
Earnings Date11/05/2026

EPS

32.29
Exceptional

P / E

0.12
Anomalous

Piotroski F-Score

2 / 9
Weak

1-Year Forecast

124.25
Transformational upside

Relative Strength

6 / 100
Severely lagging

Debt / Equity

0.07
Debt-free

Business Description

Revelation Biosciences is a San Diego-based company founded in 2019 that develops medicines designed to regulate the body's immune response and reduce harmful inflammation. Its main focus is on kidney health, with two drug candidates in development aimed at preventing and treating both sudden and long-term kidney disease. The company's core technology centers on a compound that helps restore balance to an overactive immune system.

Key Fundamentals

EPS32.29
P/E0.12
ROE-115
ROIC-974
ROA-93.68
EBITDA, mln-10.72
EV / EBITDA0.71
EV / EBIT0.70

Quote Details

Last 3.79
Change 0.11 (2.99%)
Open 3.68
Volume 16,257
Turnover 61,614
Average Volume 21,125

Financial Ratios

Leverage Ratio1.24
Current Ratio6.21
Price / Book0.32
Price / Tangible Book0.32
Debt / Equity0.07

Financial Strength

Piotroski F-Score 2 / 9
1-Year Target Price124.25
Short Ratio0.06
Short % of Float0.04

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 11.8% 93 / 100   
1 Month -37.77% 6 / 100   
2 Months -53.33% 7 / 100   
6 Months -53.72% 12 / 100   
1 Year -88.53% 4 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog